A phase II trial of erlotinib monotherapy in pretreated patients with advanced non-small cell lung cancer who do not possess active egfr mutations: Okayama lung cancer study group trial 0705

Hiroshige Yoshioka, Katsuyuki Hotta, Katsuyuki Kiura, Nagio Takigawa, Hidetoshi Hayashi, Shingo Harita, Shoichi Kuyama, Yoshihiko Segawa, Haruhito Kamei, Shigeki Umemura, Akihiro Bessho, Masahiro Tabata, Mitsune Tanimoto

Research output: Contribution to journalArticlepeer-review

61 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase II trial of erlotinib monotherapy in pretreated patients with advanced non-small cell lung cancer who do not possess active egfr mutations: Okayama lung cancer study group trial 0705'. Together they form a unique fingerprint.

Medicine & Life Sciences